Personalised medicine for Familial Hypercholesterolemia – pilot study

Abstract

Familial Hypercholesterolemia (FH) confers a high risk for cardiovascular disease (CVD) with several modulating characteristics, which makes it the perfect candidate for personalised medicine approaches.With thanks to the EAS for support in the form of a Young Investigator FellowshipN/

    Similar works